Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)

China flag China · Delayed Price · Currency is CNY
4.380
+0.030 (0.69%)
Mar 10, 2026, 11:29 AM CST
0.23%
Market Cap 11.03B
Revenue (ttm) 6.58B
Net Income (ttm) 687.99M
Shares Out 2.54B
EPS (ttm) 0.27
PE Ratio 15.92
Forward PE n/a
Dividend 0.15 (3.44%)
Ex-Dividend Date Jun 25, 2025
Volume 22,054,775
Average Volume 44,554,364
Open 4.370
Previous Close 4.350
Day's Range 4.350 - 4.380
52-Week Range 4.160 - 4.900
Beta 0.32
RSI 36.04
Earnings Date Apr 23, 2026

About SHA:600572

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nutritional supplements, hygiene products, healthy daily chemicals and food, and other self-care products; and processes agricultural products. In additio... [Read more]

Sector Healthcare
Founded 1969
Employees 8,411
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600572
Full Company Profile

Financial Performance

In 2024, SHA:600572's revenue was 6.52 billion, a decrease of -3.23% compared to the previous year's 6.73 billion. Earnings were 622.42 million, an increase of 5.21%.

Financial Statements

News

There is no news available yet.